Unlocking the Potential: Cyclooxygenase 1 Inhibitors - Guardians of Inflammation Control

Cyclooxygenase 1 inhibitors are a kind of non-steroidal anti-inflammatory drugs. Cyclooxygenase 1 is a type of enzyme that is primarily responsible for pain and inflammation. They are mainly responsible for the production of prostaglandins. The induction of COX2 during inflammation has caused the development of several nonselective therapeutic COX1 and COX2 inhibitors that includes ibuprofen, flurbiprofen, fenoprofen

Data Bridge Market Research analyses a growth rate in the cyclooxygenase 1 inhibitor market in the forecast period 2023-2030. The expected CAGR of cyclooxygenase 1 inhibitor market is tend to be around 7% in the mentioned forecast period. The market is valued at USD 70 billion in 2022, and it would grow upto USD 120.27 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Cyclooxygenase 1 Inhibitor Market Dynamics
Drivers

Increasing Prevalence of Cancer

According to Cancer.org, men tend to have a 1 in 23 lifetime risk of having cancer, on the other hand, women have a 1 in 25. Cancer is the third most cause of mortality in men and the second most common cancer in women. Around 1.8 million new cases were observed in 2018. Around 39% of cases are diagnosed at an early stage. The 5-year survival rate is nearly 71% if cancer locates to neighbouring tissues, organs, or regional lymph nodes. Thus, this factor boost the market growth.

Get More Info : https://www.databridgemarketresearch.com/reports/global-cyclooxygenase-1-inhibitor-market

Global Cyclooxygenase 1 Inhibitor Market Scope
The cyclooxygenase 1 inhibitor market is segmented on the basis of application, types, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Application
• Inflammatory diseases
• Gastrointestinal toxicity
• Others

Key players operating in the cyclooxygenase 1 inhibitor market include:
• Jsn Technologies (U.K.)
• Boehringer Ingelheim International GmbH (Germany)
• Bayer AG (Germany)
• Sabinsa (U.S.)
• Cadila Pharmaceuticals. (India)
• Mylan N.V (U.S.)

More Links:
https://dbmr232343.blogspot.com/2023/06/fanconi-anaemia-treatment-market.html

https://dbmr232343.blogspot.com/2023/06/angiotensin-converting-enzyme-ace.html

https://dbmr232343.blogspot.com/2023/06/athletes-foot-drugs-market-industry.html

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

This release was published on openPR.